Fatal overdose with citalopram

  title={Fatal overdose with citalopram},
  author={Mats {\"O}str{\"o}m and Anders Eriksson and Jan Thorson and Olav Spigset},
  journal={The Lancet},

Topics from this paper

QTc Interval Prolongation Associated with Citalopram Overdose: A Case Report and Literature Review
The case of a healthy 21-year-old woman who developed QTc interval prolongation after ingestion of approximately 400 mg citalopram is reported, and the cardiac effects of cITALopram are discussed. Expand
The Authors’ Reply
The authors’ reply: Nothing is certain in medicine and, while there is a remote possibility that citalopram could have contributed to the deaths, some clinicians might decide to err on the side of safety and not choose citalipram as first-line treatment given the availability of suitable alternative drugs. Expand
Drug monitoring of a case of citalopram overdosage
The case of a 54-year-old patient who developed QTc interval prolongation, followed by ventricular fibrillation episodes, 10 hours after admission to the ICU, in the setting of a citalopram overdose is reported. Expand
Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
The data provided are useful for the therapeutic monitoring of pharmacotherapies, to facilitate the diagnostic assessment and monitoring of acute and chronic intoxications as well as to support forensic and clinical expert opinions. Expand
Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose
A QT reporting checklist is reported to ensure published case reports and series describing drug-induced QT interval prolongation in poisoning can contribute to the fund of knowledge of QT intervals prolongation, TdP and other malignant dysrhythmias. Expand
Postmortem analysis of human bone marrow aspirate - Quantitative determination of SSRI and SNRI drugs.
For the first time the MAE/UHPLC-TOFMS method was developed and used in order to determine the antidepressant drugs within the human bone marrow aspirate in real forensic cases and allows for quantification of all mentioned drugs at therapeutic levels. Expand
Distribution of Eight QT-Prolonging Drugs and Their Main Metabolites Between Postmortem Cardiac Tissue and Blood Reveals Potential Pitfalls in Toxicological Interpretation.
Cardiac tissue and femoral and cardiac blood concentrations were examined for eight frequently used QT-prolonging drugs (QTD) and their metabolites in a mentally ill population and citalopram displayed a wide overlap in cardiac tissue concentrations between non-toxic and toxic cITALopram cases, as estimated from femoral blood concentrations. Expand
The role of chronic nutritional supplements consumption in a fulminant serotonin syndrome due to citalopram intoxication.
The case of a previously healthy 42-yearold man with a history of chronic tobacco and alcohol consumption who was recently diagnosed for depression, who took a moderated overdose of citalopram and alcohol and died after 72 h, is reported. Expand
Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review
Both beneficial and adverse cardiovascular events can be established following the chronic use of various types of SSRIs, and the cardiovascular effect of each SSRI has to be carefully considered, based on patients' cardiovascular risk profiles. Expand
Citalopram Overdose: a Fatal Case
The clinician must be aware of the potential for large ingestions of citalopram to produce life-threatening effects and monitor closely for the neurologic, cardiovascular, and other manifestations that, in rare cases, can be fatal. Expand


Blood and tissue concentrations of tricyclic antidepressant drugs in post mortem cases: literature survey and a study of forty deaths.
Comparing TCA drug concentrations in the heart and skeletal muscle and considering the differences in perfusion to these organs, TCA drugs and metabolites showed an affinity for the cardiac over the skeletal muscle. Expand
Studies on acute toxicity and drug levels of citalopram in the dog.
Since no electrocardiographic changes were seen in conscious dogs even during pauses in the convulsive seizure it is concluded that citalopram does not exert cardiotoxic effects in the dog. Expand